Symposium:
17. What's Hot in ID and HIV
Thursday, October 20, 2011: 2:45 PM-4:45 PM
Room: 210ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify important publications from the past year's HIV and ID literature
  • apply lessons from these publications to clinical practice
  • develop new research strategies as a result

Target Audience: Scientists, Researchers, Pharmacists, Infectious Diseases Physicians, HIV Clinicians, Clinicians

Tracks: HIV, Adult ID

Moderators:  Joel Ernst, MD, FIDSA, New York University School of Medicine and Joel Gallant, MD, MPH, FIDSA, John Hopkins University School of Medicine

Presentations:

2:45 PM
83
HIV: Basic Science
Michael Lederman, MD, FIDSA

3:15 PM
84
ID Clinical Science
John G. Bartlett, MD, FIDSA

3:45 PM
85
What's Hot in ID Basic Science?
Joel Ernst, MD, FIDSA

4:15 PM
86
HIV:Clinical
Judith Aberg, MD, FIDSA

CME Credits: Maximum of 2.0 hours of Category 1 credit possible

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-148-L01-P

Disclosures:

J. Ernst, None

J. Gallant, Bristol-Myers Squibb: Scientific Advisor, Consulting fee
Gilead Sciences: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient
Merck & Co.: Scientific Advisor, Consulting fee
Janssen Therapeutics: Scientific Advisor, Consulting fee
Sangamo Biosciences: Scientific Advisor, Consulting fee
RAPID Pharmaceuticals: Consultant, Consulting fee

M. Lederman, None

J. G. Bartlett, None

J. Ernst, None

J. Aberg, KOWA Research Institute: Consultant, Consulting fee
Viiv: Scientific Advisor, Consulting fee
Merck: Scientific Advisor, Consulting fee
Tibotec: Scientific Advisor, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.